Why insider trading matters?
When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-07-26 | LARUE WILLIAM R | Director | Buy | 6,545 | $3.82 | $25,002 | No |
| 2021-03-08 | Brown Scott B. | Chief Financial Officer | Buy | 1,000 | $8.30 | $8,296 | No |
| 2021-01-27 | THEUER CHARLES | President and CEO | Buy | 11,000 | $8.98 | $98,771 | No |
| 2020-12-30 | Ikarian Capital, LLC | Member of 10% Group | Buy | 520,291 | $9.61 | $4,999,997 | No |
| 2020-12-29 | WIGGINS MARK C | Chief Business Officer | Buy | 1,000 | $10.57 | $10,570 | No |
| 2020-12-22 | Opaleye Management Inc. | 10%-Owner | Buy | 496,277 | $8.06 | $3,999,993 | No |
| 2020-11-11 | Ikarian Capital, LLC | Member of 10% Group | Buy | 34,000 | $5.10 | $173,269 | No |
| 2020-10-21 | Opaleye Management Inc. | 10%-Owner | Buy | 8,656 | $4.40 | $38,060 | No |
| 2020-10-21 | THEUER CHARLES | President and CEO | Buy | 2,000 | $4.38 | $8,769 | No |
| 2020-09-24 | Opaleye Management Inc. | 10%-Owner | Buy | 78,734 | $4.73 | $372,095 | No |
| 2020-09-23 | THEUER CHARLES | President and CEO | Buy | 5,000 | $4.72 | $23,599 | No |
| 2020-09-11 | Ikarian Capital, LLC | Member of 10% Group | Buy | 322,471 | $3.28 | $1,057,387 | No |
| 2020-09-11 | Ikarian Capital, LLC | Member of 10% Group | Buy | 322,471 | $3.28 | $1,057,387 | No |
| 2020-09-10 | WIGGINS MARK C | Chief Business Officer | Buy | 7,000 | $4.14 | $28,953 | No |
| 2020-09-09 | Opaleye Management Inc. | 10%-Owner | Buy | 56,558 | $3.38 | $190,902 | No |
| 2020-09-04 | THEUER CHARLES | President and CEO | Buy | 10,000 | $2.58 | $25,750 | No |
| 2020-09-02 | Opaleye Management Inc. | 10%-Owner | Buy | 159,800 | $2.28 | $363,825 | No |
| 2020-08-31 | Opaleye Management Inc. | 10%-Owner | Buy | 545,504 | $1.74 | $950,378 | Yes |
| 2020-08-21 | THEUER CHARLES | President and CEO | Buy | 5,325 | $1.56 | $8,307 | No |
| 2020-08-20 | THEUER CHARLES | President and CEO | Buy | 30,000 | $1.58 | $47,400 | No |
| 2020-08-18 | THEUER CHARLES | President and CEO | Buy | 44,843 | $1.63 | $73,021 | No |
| 2020-08-13 | THEUER CHARLES | President and CEO | Buy | 20,000 | $1.73 | $34,500 | No |
| 2020-06-24 | THEUER CHARLES | President and CEO | Buy | 9,895 | $1.90 | $18,800 | No |
| 2020-06-15 | PELLETIER SAUNDRA L | Director | Buy | 5,500 | $2.04 | $11,209 | Yes |
| 2020-05-22 | THEUER CHARLES | President and CEO | Buy | 10,592 | $1.90 | $20,119 | No |
| 2020-03-13 | THEUER CHARLES | President and CEO | Buy | 4,100 | $1.13 | $4,624 | No |
| 2020-03-12 | THEUER CHARLES | President and CEO | Buy | 20,000 | $1.43 | $28,639 | No |
| 2020-03-10 | THEUER CHARLES | President and CEO | Buy | 10,000 | $1.87 | $18,691 | No |
| 2020-01-23 | WIGGINS MARK C | Chief Business Officer | Buy | 5,000 | $4.02 | $20,102 | No |
| 2019-12-09 | Puissance Cross-Border Opportunities V LLC | 10%-Owner | Sell | 384,130 | $2.93 | $1,127,379 | No |
Insider Smart
Insider Smart